Pure Midwest

CBD News Aggregator

Will Hexo Rebound with Its Molson Coors CBD Deal?

Hexo (TSE:HEXO) has been struggling for a while now and things aren’t looking good. The stock has lost close to 70.2% year-to-date. As a result, the stock is also at risk of getting delisted. Cannabis stocks have risen due to increased demand and sales. However, the surge might not be enough to help revive the stock. Recently, Hexo announced another deal with Molson Coors to expand its CBD footprint in the US. Will it help Hexo recover in 2020?

Leave a Reply

woocommerce social proof plugin
%d bloggers like this: